IL193369A0 - A nebulizer formulation and kit containing formoterol and budesonide - Google Patents

A nebulizer formulation and kit containing formoterol and budesonide

Info

Publication number
IL193369A0
IL193369A0 IL193369A IL19336908A IL193369A0 IL 193369 A0 IL193369 A0 IL 193369A0 IL 193369 A IL193369 A IL 193369A IL 19336908 A IL19336908 A IL 19336908A IL 193369 A0 IL193369 A0 IL 193369A0
Authority
IL
Israel
Prior art keywords
budesonide
kit containing
nebulizer formulation
containing formoterol
formoterol
Prior art date
Application number
IL193369A
Other languages
English (en)
Original Assignee
Breath Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Breath Ltd filed Critical Breath Ltd
Publication of IL193369A0 publication Critical patent/IL193369A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL193369A 2006-03-01 2008-08-11 A nebulizer formulation and kit containing formoterol and budesonide IL193369A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0604141.2A GB0604141D0 (en) 2006-03-01 2006-03-01 Nebulizer formulation
PCT/GB2007/000722 WO2007099329A2 (en) 2006-03-01 2007-03-01 Nebulizer formulation

Publications (1)

Publication Number Publication Date
IL193369A0 true IL193369A0 (en) 2009-05-04

Family

ID=36218946

Family Applications (1)

Application Number Title Priority Date Filing Date
IL193369A IL193369A0 (en) 2006-03-01 2008-08-11 A nebulizer formulation and kit containing formoterol and budesonide

Country Status (14)

Country Link
US (1) US20070207091A1 (enExample)
EP (1) EP1988876A2 (enExample)
JP (1) JP2009528337A (enExample)
KR (1) KR20080098631A (enExample)
CN (1) CN101394835A (enExample)
AU (1) AU2007220288B2 (enExample)
BR (1) BRPI0708170A2 (enExample)
CA (1) CA2643761A1 (enExample)
GB (1) GB0604141D0 (enExample)
IL (1) IL193369A0 (enExample)
NO (1) NO20083683L (enExample)
NZ (1) NZ570432A (enExample)
WO (1) WO2007099329A2 (enExample)
ZA (1) ZA200806929B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
GB0700380D0 (en) 2007-01-09 2007-02-14 Breath Ltd Storage Of Ampoules
NZ587561A (en) * 2008-02-26 2012-10-26 Elevation Pharmaceuticals Inc Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations (an muscarinic antagnoist)
US20100055045A1 (en) 2008-02-26 2010-03-04 William Gerhart Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
WO2010144628A2 (en) * 2009-06-09 2010-12-16 Elevation Pharmaceuticals, Inc. Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration
US20140296641A1 (en) * 2013-03-28 2014-10-02 William Randolph Warner COMPOSITIONS, FORMULATIONS AND METHODS OF BIO-BALANCING THE pH OF STERILE HYPOTONIC, ISOTONIC SALINE AND HYPERTONIC SALINE SOLUTIONS
GB201416909D0 (en) * 2014-09-25 2014-11-12 Prosonix Ltd Method of forming concentrated solution
CN107233311B (zh) * 2017-06-27 2020-12-04 长风药业股份有限公司 一种以阿福特罗和格隆溴铵为活性成分的雾化剂及其制备方法
US20190231769A1 (en) * 2017-10-27 2019-08-01 Nephron Pharmaceuticals Corporation Tiotropium Inhalation Solution for Nebulization

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3342484B2 (ja) * 1991-12-18 2002-11-11 アストラ・アクチエボラーグ 新規な配合
SE9703407D0 (sv) * 1997-09-19 1997-09-19 Astra Ab New use
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6946117B1 (en) * 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
SE9802073D0 (sv) * 1998-06-11 1998-06-11 Astra Ab New use
US7074388B2 (en) * 1998-12-10 2006-07-11 Kos Life Science, Inc. Water stabilized medicinal aerosol formulation
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
IT1313553B1 (it) * 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US20060171897A1 (en) * 1999-12-23 2006-08-03 Coifman Robert E Methods and formulations for the efficient delivery of drugs by nebulizer
US6451289B2 (en) * 2000-03-24 2002-09-17 Sepracor Inc. Albuterol formulations
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
BR0115584A (pt) * 2000-11-24 2003-09-23 Breath Ltd Esterilização de produtos farmacêuticos
ITMI20010428A1 (it) * 2001-03-02 2002-09-02 Chemo Breath S A Composizioni ad uso inalatorio a base di formoterolo
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
SE0200312D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
DK1476201T3 (da) * 2002-02-19 2009-03-30 Resolution Chemicals Ltd Solvent-baseret sterilisering af steroider
SE0203376D0 (sv) * 2002-11-15 2002-11-15 Astrazeneca Ab New process
SE526509C2 (sv) * 2003-06-19 2005-09-27 Microdrug Ag Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
DE10347994A1 (de) * 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Wässrige Aerosol-Zubereitung
US20050214224A1 (en) * 2003-11-04 2005-09-29 Nektar Therapeutics Lipid formulations for spontaneous drug encapsulation
US20070053842A1 (en) * 2003-12-12 2007-03-08 Joseph Okpala Method of engineering particles for use in the delivery of drugs via inhalation
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition

Also Published As

Publication number Publication date
WO2007099329A3 (en) 2007-10-25
KR20080098631A (ko) 2008-11-11
NZ570432A (en) 2010-09-30
CA2643761A1 (en) 2007-09-07
US20070207091A1 (en) 2007-09-06
AU2007220288B2 (en) 2012-12-13
WO2007099329A2 (en) 2007-09-07
AU2007220288A1 (en) 2007-09-07
EP1988876A2 (en) 2008-11-12
NO20083683L (no) 2008-12-01
GB0604141D0 (en) 2006-04-12
ZA200806929B (en) 2009-11-25
BRPI0708170A2 (pt) 2011-05-17
CN101394835A (zh) 2009-03-25
JP2009528337A (ja) 2009-08-06

Similar Documents

Publication Publication Date Title
IL193369A0 (en) A nebulizer formulation and kit containing formoterol and budesonide
IL250937A0 (en) Pharmaceutical preparations and kits containing sphingomyelinase acid
IL194868A (en) Use of 1-task and 3-task ion channel inhibitors for drug preparation
SI2957278T1 (sl) Stabilni sestavek, ki obsega PTHrP, in njegova uporaba
GB0721739D0 (en) medicinal inhalation devices and components thereof
GB0621957D0 (en) Inhaler devices and bespoke pharmaceutical compositions
SI2001556T1 (sl) Tioninijeve spojine in njihova uporaba
GB2443336B (en) Spiruchostatin analogues and their medicinal use
EP2040698A4 (en) OXIM CONNECTIONS AND ITS USE
IL194899A0 (en) Amino-ethyl-amino-aryl (aeaa) compounds and their use
EP2205301A4 (en) MEDICAL INHALATION DEVICES AND COMPONENTS THEREOF
IL199904A0 (en) Compositions comprising a therapeutic agent and an alkoxy-polyethylene glycol and uses thereof
PL2012805T3 (pl) Kompozycja lecznicza i jej zastosowanie
IL183578A0 (en) Use of levalbuterol and ipratropium in a nebulizer formulation
IL202297A0 (en) Valve and dispenser
GB0611115D0 (en) Compounds and their use
PL2094138T3 (pl) Połączony elektroniczny dozownik i odświeżacz powietrza
IL195726A0 (en) Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant
ZA200800177B (en) A composition for wound healing and use thereof
EP1957693A4 (en) TUBE AND USE OF SAID TUBE
IL192820A0 (en) Novel compounds and use thereof
ZA200807390B (en) Topical composition and use thereof
EP2073817A4 (en) MEDIC ACID SAPONINE AND ITS USES
AP2006003734A0 (en) Inhalation formulation
HUP0600122A3 (en) New compounds and their use